|
of
European companies with activities in animal cell
technology.
If
you want to know who we are, what we do and what
our aims are, then visit the page with information
on our Objectives
and our Members.
In short, we follow cutting-edge developments in
research and production related to animal cell
technology. We cover both industrial and academic
issues.
Our
members
are European companies with activities in
animal
cell technology.
This technology is applied for the production of
biopharmaceuticals,
monoclonal
antibodies,
vaccines,
gene
therapy
vectors and for safety
testing.
The members also follow issues related to
Transmissable
Spongiform Encephalopathies
(TSEs).
Day
to day business is taken care of by a
Steering
Commitee
and a Secretariat.
The
member
page
provides links to our member company's own websites
and gives information on how to apply for
membership. Members are provided with a password
giving access to the secure
part of this website, which contains European
Commission documents and minutes of the ACTIP
meetings.
Our
members meet twice a year in a plenary meeting,
hosted in the home-town of a member company. These
meetings feature high-level presentations on
selected topics, with invited speakers from
academia, our own member companies and
small
and medium-sized
companies
(SMEs). SMEs working on one of the topics covered
are invited specifically to these meetings, to
network with our members and to present their
technologies.
In
addition to our meetings, we prepare
position
papers
(for example on the research needs of industry),
monographs (see our publications
page),
information on products
and a regular newsbulletin.
New Position Paper
Input
from ACTIP on FP7 of the
Commission. |